Linda Fletcher

Linda Fletcher is a seasoned regulatory professional with extensive experience in the biopharmaceutical industry. At Day One Biopharmaceuticals, Linda served as Associate Director of Regulatory Science, where Linda acted as the primary FDA contact for tovorafenib (DAY101) and participated in cross-functional teams. Previously, at MyoKardia, Linda held the role of Manager of Regulatory Strategy, leading the US regulatory efforts for danicamtiv (MYK-491) and managing international submissions. Linda's career began at Gilead Sciences, progressing from Associate I to Senior Associate in Regulatory Affairs, where Linda supported various regulatory submissions and activities. Earlier experience includes a role as a Registered Pharmacist at Walmart Pharmacy and an internship at Jesse Brown VA Medical Center focused on pharmacy administration and quality improvement projects.